Integrated DNA Technologies, Inc. Overview
Pro stress-test →Integrated DNA Technologies (IDT), headquartered in Coralville, Iowa, is a supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. IDT is a part of Danaher Corporation. The company has evolved from a pure oligonucleotide manufacturer to a diversified genomics platform spanning research, oncology diagnostics, and synthetic biology applications.
Strategic Profile
Pro stress-test →In April 2026, IDT announced the expansion of its manufacturing footprint in Coralville, Iowa, delivering a more than threefold increase in synthesis capacity to support next-generation sequencing (NGS)-based oncology workflows, including minimal residual disease (MRD) applications. In March 2026, the company announced its entry into the clinical diagnostics market with the launch of its first in vitro diagnostic (IVD) NGS assay solutions. This dual focus on manufacturing scale and clinical market expansion positions IDT as a key enabler in precision oncology diagnostics.
Competitive Landscape
Pro stress-test →IDT competes in the oligonucleotide synthesis and NGS/genomics space against specialized players (Eurofins Genomics, Twist Bioscience, Synthego) and larger diagnostics/life sciences firms (Illumina, Roche, Thermo Fisher). IDT's competitive advantages include vertically integrated synthesis capabilities, established customer relationships across research and pharma, Danaher's scale and regulatory infrastructure, and recent expansion into clinical diagnostics where compliance barriers favor established players.
Industry Context
Integrated DNA Technologies, Inc. operates in Oligonucleotide synthesis and genomic reagents.
Key facts
Founded: 1987 · Headquarters: Coralville, Iowa, US · Employees: ~1,560 · Revenue: $650.1M (2026) · Market cap: N/A